PBYI logo

Puma Biotechnology (PBYI) Cash From Financing

Annual CFF

$0.00
-$12.22 M-100.00%

December 31, 2023

Summary

Performance

1-Year Change

-100%

3-Year Change

+100%

5-Year Change

-100%

15-Year Change

-100%

PBYI Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

27.41%
PBYI annual cash flow from financing activities is higher than 27.41% of companies in Healthcare sector

High & Low

All-time High

$233.36 M
PBYI annual cash flow from financing activities is currently -100.00% below its historical high of $233.36 million

3-Year Low

-$31.93 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
PBYI previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
PBYI next annual earnings announcement is scheduled for Feb 28, 2025

OtherPBYIcash flowmetrics:

Annual CFI

-$19.13 M
PBYI annual cash flow from investing activities is -$19.13 million

Annual CFO

$27.01 M
PBYI annual cash flow from operations is $27.01 million

Annual FCF

$14.37 M
PBYI annual free cash flow is $14.37 million

Annual CAPEX

$12.64 M
PBYI annual capital expenditures is $12.64 million

Quarterly CFF

-$11.18 M
+$149.00 K+1.31%

September 30, 2024

Summary

Performance

3-Month Change

+1.31%

1-Year Change

-100%

3-Year Change

-100%

5-Year Change

-100%

PBYI Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

10.6%
PBYI quarterly cash flow from financing activities is higher than 10.6% of companies in Healthcare sector

High & Low

All-time High

$219.63 M
PBYI quarterly cash flow from financing activities is currently -105.09% below its historical high of $219.63 million

3-Year Low

-$11.33 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
PBYI previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
PBYI next earnings announcement is scheduled for Feb 28, 2025

OtherPBYIcash flowmetrics:

Quarterly CFI

$259.00 K
PBYI quarterly cash flow from investing activities is $259.00 thousand

Quarterly CFO

$11.04 M
PBYI quarterly cash flow from operations is $11.04 million

Quarterly FCF

$11.02 M
PBYI quarterly free cash flow is $11.02 million

Quarterly CAPEX

$20.00 K
PBYI quarterly capital expenditures is $20.00 thousand

TTM CFF

-$22.52 M
-$11.18 M-98.69%

September 30, 2024

Summary

Performance

3-Month Change

-98.69%

1-Year Change

-1026.16%

3-Year Change

-1.94%

5-Year Change

-1.94%

PBYI TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

12.87%
PBYI TTM cash flow from financing activities is higher than 12.87% of companies in Healthcare sector

High & Low

All-time High

$238.57 M
PBYI TTM cash flow from financing activities is currently -109.44% below its historical high of $238.57 million

3-Year Low

-$31.93 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
PBYI previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
PBYI next earnings announcement is scheduled for Feb 28, 2025

OtherPBYIcash flowmetrics:

TTM CFI

-$26.29 M
PBYI TTM cash flow from investing activities is -$26.29 million

TTM CFO

$33.77 M
PBYI TTM cash flow from operations is $33.77 million

TTM FCF

$33.68 M
PBYI TTM free cash flow is $33.68 million

TTM CAPEX

$85.00 K
PBYI TTM capital expenditures is $85.00 thousand

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

PBYI Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-100.0%-100.0%-1026.2%
3 y3 years+100.0%-100.0%-1.9%
5 y5 years-100.0%-100.0%-1.9%

PBYI Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-100.0%+100.0%-213.6%+1.3%-284.2%+29.5%
5 y5-year-100.0%+100.0%-213.6%+65.0%-284.2%+66.4%
alltimeall time-100.0%+100.0%-105.1%+83.6%-109.4%+66.4%

Puma Biotechnology Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
-$11.18 M(-1.3%)
-$22.52 M(+98.7%)
Jun 2024
-
-$11.33 M(<-9900.0%)
-$11.33 M(<-9900.0%)
Mar 2024
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2023
$0.00(-100.0%)
$0.00(0.0%)
$0.00(-100.0%)
Sep 2023
-
$0.00(0.0%)
$2.43 M(+2.2%)
Jun 2023
-
$0.00(0.0%)
$2.38 M(0.0%)
Mar 2023
-
$0.00(-100.0%)
$2.38 M(-80.5%)
Dec 2022
$12.22 M(-138.3%)
$2.43 M(-4686.8%)
$12.22 M(+24.9%)
Sep 2022
-
-$53.00 K(<-9900.0%)
$9.79 M(-144.3%)
Jun 2022
-
$0.00(-100.0%)
-$22.09 M(0.0%)
Mar 2022
-
$9.85 M(<-9900.0%)
-$22.09 M(-30.8%)
Dec 2021
-$31.93 M(+221.5%)
-$2000.00(-100.0%)
-$31.93 M(-23.8%)
Sep 2021
-
-$31.93 M(<-9900.0%)
-$41.91 M(+321.8%)
Jun 2021
-
$0.00(0.0%)
-$9.93 M(+0.0%)
Mar 2021
-
$0.00(-100.0%)
-$9.93 M(0.0%)
Dec 2020
-$9.93 M(-85.2%)
-$9.98 M(<-9900.0%)
-$9.93 M(<-9900.0%)
Sep 2020
-
$43.00 K(+2050.0%)
$44.00 K(-42.9%)
Jun 2020
-
$2000.00(-300.0%)
$77.00 K(-100.1%)
Dec 2019
-$67.07 M(-161.8%)
-$1000.00(-101.3%)
-$67.07 M(+83.4%)
Sep 2019
-
$76.00 K(-100.1%)
-$36.57 M(+2.6%)
Jun 2019
-
-$68.22 M(-6405.4%)
-$35.64 M(-133.5%)
Mar 2019
-
$1.08 M(-96.5%)
$106.39 M(-1.9%)
Dec 2018
$108.45 M(+44.4%)
$30.49 M(+2919.0%)
$108.45 M(-22.0%)
Sep 2018
-
$1.01 M(-98.6%)
$139.07 M(-5.9%)
Jun 2018
-
$73.80 M(+2245.2%)
$147.79 M(+90.6%)
Mar 2018
-
$3.15 M(-94.9%)
$77.55 M(+3.2%)
Dec 2017
$75.11 M(-53.8%)
$61.11 M(+528.0%)
$75.11 M(-57.3%)
Sep 2017
-
$9.73 M(+173.0%)
$176.08 M(+5.8%)
Jun 2017
-
$3.56 M(+405.0%)
$166.48 M(+2.2%)
Mar 2017
-
$706.00 K(-99.6%)
$162.91 M(+0.3%)
Dec 2016
$162.43 M
$162.08 M(>+9900.0%)
$162.43 M(+9620.5%)
Sep 2016
-
$129.00 K(>+9900.0%)
$1.67 M(-75.8%)
Jun 2016
-
$0.00(-100.0%)
$6.92 M(-50.4%)
DateAnnualQuarterlyTTM
Mar 2016
-
$222.00 K(-83.2%)
$13.95 M(-94.0%)
Dec 2015
$233.36 M(+71.6%)
$1.32 M(-75.4%)
$233.36 M(-2.2%)
Sep 2015
-
$5.37 M(-23.6%)
$238.57 M(+2.3%)
Jun 2015
-
$7.03 M(-96.8%)
$233.20 M(+3.1%)
Mar 2015
-
$219.63 M(+3261.9%)
$226.17 M(+66.3%)
Dec 2014
$135.97 M(+6038.7%)
$6.53 M(>+9900.0%)
$135.97 M(+3.4%)
Sep 2014
-
$0.00(0.0%)
$131.51 M(-0.1%)
Jun 2014
-
$0.00(-100.0%)
$131.66 M(0.0%)
Mar 2014
-
$129.44 M(+6156.2%)
$131.66 M(+5843.8%)
Dec 2013
$2.21 M(-98.3%)
$2.07 M(+1317.1%)
$2.21 M(-98.3%)
Sep 2013
-
$146.00 K(>+9900.0%)
$129.41 M(+0.1%)
Jun 2013
-
$0.00(0.0%)
$129.26 M(0.0%)
Mar 2013
-
$0.00(-100.0%)
$129.26 M(0.0%)
Dec 2012
$129.26 M(+127.0%)
$129.26 M(>+9900.0%)
$129.26 M(+127.8%)
Sep 2012
-
$0.00(0.0%)
$56.74 M(-0.3%)
Jun 2012
-
$0.00(0.0%)
$56.91 M(-0.1%)
Mar 2012
-
$0.00(-100.0%)
$56.95 M(-0.0%)
Dec 2011
$56.95 M(>+9900.0%)
$56.74 M(>+9900.0%)
$56.95 M(>+9900.0%)
Sep 2011
-
$168.70 K(+328.2%)
$206.70 K(+398.1%)
Jun 2011
-
$39.40 K(+910.3%)
$41.50 K(+558.7%)
Mar 2011
-
$3900.00(-173.6%)
$6300.00(-10.0%)
Dec 2010
$7000.00(-63.5%)
-$5300.00(-251.4%)
$7000.00(-55.4%)
Sep 2010
-
$3500.00(-16.7%)
$15.70 K(+1.9%)
Jun 2010
-
$4200.00(-8.7%)
$15.40 K(-3.8%)
Mar 2010
-
$4600.00(+35.3%)
$16.00 K(-16.2%)
Dec 2009
$19.20 K(+82.9%)
$3400.00(+6.3%)
$19.10 K(+6.7%)
Sep 2009
-
$3200.00(-33.3%)
$17.90 K(+21.8%)
Jun 2009
-
$4800.00(-37.7%)
$14.70 K(+14.0%)
Mar 2009
-
$7700.00(+250.0%)
$12.90 K(+22.9%)
Dec 2008
$10.50 K
$2200.00(>+9900.0%)
$10.50 K(+26.5%)
Sep 2008
-
$0.00(-100.0%)
$8300.00(0.0%)
Jun 2008
-
$3000.00(-43.4%)
$8300.00(+56.6%)
Mar 2008
-
$5300.00
$5300.00

FAQ

  • What is Puma Biotechnology annual cash flow from financing activities?
  • What is the all time high annual CFF for Puma Biotechnology?
  • What is Puma Biotechnology annual CFF year-on-year change?
  • What is Puma Biotechnology quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Puma Biotechnology?
  • What is Puma Biotechnology quarterly CFF year-on-year change?
  • What is Puma Biotechnology TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Puma Biotechnology?
  • What is Puma Biotechnology TTM CFF year-on-year change?

What is Puma Biotechnology annual cash flow from financing activities?

The current annual CFF of PBYI is $0.00

What is the all time high annual CFF for Puma Biotechnology?

Puma Biotechnology all-time high annual cash flow from financing activities is $233.36 M

What is Puma Biotechnology annual CFF year-on-year change?

Over the past year, PBYI annual cash flow from financing activities has changed by -$12.22 M (-100.00%)

What is Puma Biotechnology quarterly cash flow from financing activities?

The current quarterly CFF of PBYI is -$11.18 M

What is the all time high quarterly CFF for Puma Biotechnology?

Puma Biotechnology all-time high quarterly cash flow from financing activities is $219.63 M

What is Puma Biotechnology quarterly CFF year-on-year change?

Over the past year, PBYI quarterly cash flow from financing activities has changed by -$11.18 M (-100.00%)

What is Puma Biotechnology TTM cash flow from financing activities?

The current TTM CFF of PBYI is -$22.52 M

What is the all time high TTM CFF for Puma Biotechnology?

Puma Biotechnology all-time high TTM cash flow from financing activities is $238.57 M

What is Puma Biotechnology TTM CFF year-on-year change?

Over the past year, PBYI TTM cash flow from financing activities has changed by -$24.95 M (-1026.16%)